|
Laboratory findings, Initial
|
|
Hemoglobin (mg/dL)
|
12.7 (10.5–14.7)
|
12.2 (10.5–14.0)
|
0.039
|
|
Serum glucose (mg/dL)
|
222.0 (150.0–319.0)
|
183.0 (134.0–269.0)
|
0.001
|
|
Total bilirubin (mg/dL)
|
0.6 (0.4–1.2)
|
0.7 (0.5–1.2)
|
0.021
|
|
Creatinine (mg/dL)
|
1.3 (1.0–1.7)
|
1.2 (0.9–1.8)
|
0.085
|
|
Lactate (mmol/L, at admission)
|
6.9 (4.7–1.0)
|
3.7 (2.3–7.1)
|
< 0.001
|
|
Lactate (mmol/L, 24 h after admission)
|
1.2 (0.9–1.7)
|
2.3 (1.4–6.8)
|
< 0.001
|
|
Lactate clearance (%)
|
80.0 (72.1–86.5)
|
36.2 (0.0–53.6)
|
< 0.001
|
|
NT–proBNP (pg/mL)
|
5884.5 (1015.5–21,827.8)
|
5152.0 (1506.5–13,628.5)
|
0.424
|
|
Vasoactive inotropic score
|
27.7 (8.0–80.0)
|
37.0 (10.0–110.0)
|
0.006
|
|
Use of venous central line
|
218 (65.5)
|
200 (67.8)
|
0.537
|
|
Use of mechanical circulatory support
|
0.134
|
|
None
|
138 (41.4)
|
97 (32.9)
| |
|
ECMO
|
126 (37.8)
|
127 (43.1)
| |
|
IABP
|
51 (15.3)
|
48 (16.3)
| |
|
ECMO + IABP
|
18 (5.4)
|
23 (7.8)
| |
|
Shock-to-ECMO time < 24 h
|
126 (37.8)
|
133 (45.1)
|
0.066
|
|
ECPR
|
62 (18.6)
|
72 (24.4)
|
0.077
|
|
Continuous renal replacement therapy
|
75 (22.5)
|
109 (36.9)
|
< 0.001
|
|
Mechanical ventilation
|
219 (65.8)
|
198 (67.1)
|
0.720
|
|
Length of intensive care unit stay (day)
|
8.0 (4.0–16.5)
|
6.0 (2.0–15.0)
|
0.002
|
|
Length of hospital stay (day)
|
14.0 (8.0–28.0)
|
11.0 (5.0–27.0)
|
0.001
|
